FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

2.

Researchers explore e-bikes for cancer recovery

3.

According to new studies, some cancer patients can safely forego radiation therapy.

4.

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

5.

A single bout of exercise gives results that could help cancer patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot